Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Parathyroid hormone  (6)
  • Diabetes mellitus  (5)
  • Hemodialysis  (4)
  • Blutdruck  (2)
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 66 (1988), S. 883-891 
    ISSN: 1432-1440
    Keywords: Diabetes mellitus ; Renin ; Angiotensin II ; ACE inhibitors ; Renal function ; Blood pressure ; Diabetes mellitus ; Renin ; Angiotensin II ; ACE-Hemmer ; Nierenfunktion ; Blutdruck
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Es wird eine Übersicht gegeben über in der Literatur berichtete Befunde bei Diabetikern bezüglich der Aktivität der Komponenten des Renin-Angiotensin Systems (RAS), der Organansprechbarkeit auf Angiotensin II (ANG II), des ANG II-Rezeptorbestandes und der Auswirkungen einer Hemmung des RAS durch Angiotensin I Konversionsenzym (ACE)-Hemmer. Die Literaturübersicht zeigt, in Übereinstimmung mit eigenen Befunden, daß die Aktivität des RAS bei Diabetikern mit ausreichender Stoffwechselkontrolle normal oder eher gesteigert ist. Auch beim nephropathischen Diabetiker wird eine erhöhte, aber auch eine verringerte Aktivität des RAS angegeben. Dies widerspricht der häufig vorgetragenen Vermutung, daß das RAS bei Diabetes mellitus generell supprimiert und funktionell inaktiv ist. Letzteres wurde vor allem aus Befunden eines erniedrigten ANG II-Rezeptorbestandes bei anorektischen, schwerst hyperglykämischen Ratten geschlossen. Diese Befunde lassen sich beim Menschen nicht bestätigen, wo eher ein erhöhter ANG II-Rezeptorbestand beobachtet wurde. Dies steht im Einklang mit den häufigen Berichten, daß die Pressorantwort auf infundiertes ANG II beim Diabetiker deutlich gesteigert ist. Die gesteigerte Ansprechbarkeit hat wahrscheinlich funktionelle Bedeutung, da beim Diabetiker trotz eines erhöhten Körper-Natriumbestandes das RAS dennoch nicht, wie erwartet, supprimiert ist. Eine Reihe von Befunden sprechen auch dafür, daß die Widerstandsgefäße der Niere beim Diabetiker auf AN-G II vermehrt ansprechen. Hier könnte möglicherweise eine Ursache für die Hyperfiltration liegen. Jedenfalls wird übereinstimmend eine Verminderung der Mikroalbuminurie nach Hemmung des RAS mit ACE-Hemmern gefunden, ein möglicher indirekter Hinweis auf eine Verminderung des glomerulären kapillären Drucks.
    Notes: Summary We review available data on the activity of the renin-angiotensin system (RAS), responsiveness to angiotensin II (ANG II), ANG II receptor number, and effects of inhibition of the RAS by angiotensin I converting enzyme (ACE) inhibitors in patients with diabetes mellitus. Most authors, including ourselves, observed a normal or enhanced activity of the RAS in metabolically stable diabetics. Increased but also reduced activity of the RAS was described in nephropathic diabetes. This is in contrast to the common suggestion that the RAS of diabetics is generally suppressed and functionally inactive. The last assumption was mainly based on the finding of reduced ANG II receptor numbers in anorectic, severely hyperglycemic rats. These findings could not be reproduced in man, and a higher ANG II receptor concentration on platelets of diabetics goes in parallel with the frequent finding of an enhanced pressor response to infused ANG II in diabetes. This increased responsiveness is most probably of functional importance since the RAS is not suppressed — as one would expect — in the face of a supranormal body sodium content. A number of data also indicate that renal resistance vessels display increased responsiveness to ANG II in diabetics. This may be a reason for hyperfiltration. This notion is further supported by the reduction of albuminuria which is usually observed following inhibition of the RAS with ACE inhibitors, and which may be an index of reduction of glomerular capillary pressure in human diabetes.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1440
    Keywords: Cyclosporin A ; 1,25-Dihydroxyvitamin D3 ; Calcium metabolism ; Parathyroid hormone
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Animal studies have shown that cyclosporin A (CyA) stimulates renal 25-hydroxyvitamin D3 [25(OH)D3]-1α-hydroxylase activity; in contrast, studies in renal transplant recipients indirectly suggest that CyA reduces 1α,25-dihydroxyvitamin D3 [1,25 (OH)2D3] production. To clarify the effect of CyA on vitamin D metabolite concentrations, we measured parameters of calcium metabolism in 37 CyA-treated patients (median trough whole blood levels 171–222 ng/ml) with multiple sclerosis and initially normal kidney function. The patients participated in a randomized double-blind study to assess the efficacy of CyA in multiple sclerosis. An age- and sex-matched control group (n = 39) received azathioprine (Aza). Measurements were made at the end of a 2-year treatment period. The 1,25(OH)2D3 serum concentrations were not significantly different between the two groups, although they were numerically lower in CyA-treated patients [median (range), 28.4 pg/ml (7.8–85.9) vs 41.0 pg/ml (9.2–105.1) in Aza-treated patients]. The 25(OH)D3 levels were comparable in both groups. There was no correlation between the 25(OH)D3 and 1,25(OH)2D3 concentrations. The renal function in both groups was stable in the last 6 months of the study. At the end of the study period, the endogenous creatinine clearance was significantly lower in the CyA-treated group (85 ± 17 ml/min versus 99 ± 22 in the Aza-treated group, P 〈 0.05). The carboxyterminal parathyroid hormone (C-PTH) was within the normal range in both groups, although CyA-treated patients had significantly higher concentrations (P〈0.01). The urinary excretion of mineral ions, cations and protein was similar in both groups. Our data suggest that long-term treatment with CyA does not cause clinically important alterations of vitamin D metabolism in humans. Subtle differences in the concentrations of 1,25(OH)2D3 and C-PTH between CyA- and Aza-treated patients result presumably from a slight impairment of renal function through CyA.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 70 (1992), S. 686-691 
    ISSN: 1432-1440
    Keywords: Thiazides ; Glomerular filtration ; Hemoconcentration ; Parathyroid hormone
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary To elucidate the renal effects of thiazides as a function of sodium intake, 8 healthy volunteers without renal disease were studied at baseline and 1 day as well as 4 days after the administration of 100 mg hydrochlorothiazide/day. The subjects were compared on two different dietary sodium intakes (120 mmol/day and 220 mmol/day). Measurements comprised inulin clearance (Cin) and paraaminohippurate clearance (Cpah) by infusion clearance technique, total and ionised calcium, immunoreactive parathyroid hormone (1,84 iPTH), 1.25 (OH)2 vitamin D3, and indices of hemoconcentration. Acute administration of hydrochlorothiazide (HCTZ) caused no change in Cin (before 111 ± 3 ml/min 1.73 m2 ; 24 h after, 107 ± 2 ml/min 1.73 m2) or Cpah (before, 579 ± 9 ml/min 1.73 M2; after, 584 ± 12 ml/min 1.73 m2), while a significant (P 〈 0.01) decrease was noted on the 4th day after 100 mg HCTZ/day and normal sodium intake. No significant change of creatinine clearance (Ccr) was seen with either manouever. Renal hemodynamic changes after HCTZ administration were marginal when hemoconcentration was prevented by a high salt intake. Acute administration (1 h) of HCTZ caused suppression of 1,84 iPTH (before, 2.3 ±0.5 pmol/l; after, 1.9 ± 0.2 pmol/l; P 〈 0.01), but after 4 days a lower ionised calcium (baseline, 1.25 ± 0.01 mmol/l; day 5, 1.20 ± 0.02 mmol/l; P 〈 0.01) was noticed in parallel with hemoconcentration, metabolic alkalosis, and reduced 1,25 (OH)2 vitamin D3 concentrations. The level of 1,84 iPTH was elevated. We conclude that (i) hydrochlorothiazide does not affect the renal hemodynamics if hemoconcentration is avoided and (ii) hydrochlorothiazide acutely lowers PTH, while subacutely metabolic alkalosis and decreased ionised calcium may occur with concomitant increase in 1,84 iPTH and decrease in 1,25 (OH)2 vitamin D3 concentrations unless hemoconcentration is prevented.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 70 (1992), S. 748-751 
    ISSN: 1432-1440
    Keywords: Hypertension ; Calcium ; Parathyroid hormone ; 1,25-Dihydroxyvitamin D3
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Essential hypertension has been associated with disturbed calcium metabolism, but the available data are controversial. We measured parameters of calcium metabolism in groups of untreated male subjects (n = 78) with elevated diastolic blood pressure (101 ± 6 mmHg, mean ± SD) and age-matched male subjects (n=79) with low diastolic blood pressure (62 ± 4 mmHg). The participants of the study were drawn from a random population sample. Subjects with high diastolic blood pressure had significantly higher carboxy-terminal parathyroid hormone (PTH) plasma concentrations than controls with low diastolic blood pressure (median 114 vs. 43 pmol/l, P 〈 0.01). The 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations were comparable in both groups. Individuals with high diastolic blood pressure had significantly lower total serum calcium (2.41 ± 0.10 vs. 2.47 ± 0.10 mmol/l, mean ± SD; P 〈 0.01). PTH concentrations were correlated with diastolic pressure (r = −0.39, P 〈 0.001). The data are compatible with increased parathyroid activity despite unchanged concentrations of vitamin D metabolites in human hypertension.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 58 (1980), S. 365-370 
    ISSN: 1432-1440
    Keywords: Hepatitis A ; Hepatitis B ; Hämodialyse ; Hepatitis A ; Hepatitis B ; Hemodialysis
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary In 113 hemodialysed patients, 167 hospitalized patients, and 143 outpatients the frequency of HAV and HBV markers were studied by testing HBsAg, anti-HBs, anti-HBc, HBeAg, anti-HBe, and anti-HAV. The hemodialysis patients in a dialysiscenter had significantly more often HBV markers (85.7%) than those maintained on home-dialysis (46.5%). 29.9% of the hospitalized patients and 32.1% of the outpatients had HBV markers. By the anti-HBc test up to 41% of additional HBV infections could be detected. — The prevalence of anti-HAV was very high in all groups. Significant differences between the hemodialysis patients and the control groups existed only in the age groups up to 39 years. — The frequencies of HAV and HBV markers were related to age, duration of dialysis treatment, transfusional frequency, and transaminases. The HBV appeared as the clinically important hepatitis agent in dialysis.
    Notes: Zusammenfassung Die Häufigkeit von HAV- und HBV-Infektionen wurde bei 113 Hämodialysepatienten, 167 hospitalisierten und 146 ambulanten Patienten untersucht, indem anti-HAV, HBsAg, anti-HBs, anti-HBc, HBeAg und anti-HBe bestimmt wurden. Die Hämodialysepatienten in einem Zentrum hatten signifikant häufiger HBV-Marker (85,7%) als Heimdialysepatienten (46,5%). 29,9% der hospitalisierten und 32,1% der ambulanten Patienten hatten HBV-Marker. Der anti-HBc-Test entdeckte bis zu 41% zusätzliche HBV-Infektionen. — Die Prävalenz von anti-HAV war in allen Gruppen sehr hoch. Nur in den Altersgruppen bis 39 J. gab es signifikante Unterschiede zwischen den Hämodialysepatienten und den Kontrollgruppen. — Die Häufigkeit von HAV-und HBV-Marker wurde nach Alter, Dialysedauer, Zahl der Bluttransfusionen und Transaminasen untersucht. Das HBV erwies sich als die klinisch wichtige Hepatitisform in der Dialyse.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 59 (1981), S. 1149-1157 
    ISSN: 1432-1440
    Keywords: Hemodialysis ; Foreign body reaction ; Silicone ; Hepatosplenomegaly ; NonA, non-B Hepatitis ; Hämodialyse ; Fremdkörperreaktion ; Silikon ; Hepatosplenomegalie ; Non-A, non-B Hepatitis
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung In der vorliegenden Untersuchung wurde das Sektionsgut von 47 Patienten überprüft, die zwischen 1965 und 1980 unter Verwendung von Silikonschläuchen dialysiert wurden. Ferner wurde das Sektionsgut von zehn Patienten aus zwei Dialysezentren untersucht, in denen routinemäßig PVC Schläuche verwandt wurden. Bei 40 Patienten aus dem Zentrum mit Silikonschläuchen, bei denen die Dialysezeit unter 53 Monaten lag, konnte kein Fremdmaterial nachgewiesen werden. Bei sieben Patienten, die zwischen 52 und 165 Monaten dialysiert worden waren, zeigten sich bei der licht- und elektronenmikroskopischen Untersuchung Fremdkörpereinschlüsse in Makrophagen und Riesenzellen in folgenden Organen: Lunge, Leber, Milz, Knochenmark, Haut, thorakale und abdominale Lymphknoten. Das Material konnte in Hirn, Herz, Niere und endokrinen Organen nicht nachgewiesen werden. Fibrose, Nekrose oder Epitheloidzellreaktionen wurden nicht beobachtet. Das Fremdmaterial war nicht-isotrop, nicht kristallin und färbte sich mit Routine-Färbeverfahren nicht an. Die Elektronenmikroskopie zeigte, daß es von lysosomalen Membranen umschlossen war. Bei Patienten mit wesentlich kürzerer Dialysezeit konnte das Material in vivo durch Leberbiopsie eindeutig nachgewiesen werden. Hingegen wurde das Fremdkörpermaterial nicht gefunden bei den zehn Langzeithämodialyse-Patienten aus den zwei Zentren, die nicht routinemäßig Silikonschläuche verwandten. Alle Patienten mit positivem Nachweis wiesen eine Hepatosplenemegalie auf, viele Patienten hatten Transaminasen-Erhöhungen, ein Patient hatte Hypersplenismus mit Panzytopenie und ein Patient hatte ein Gallengangskarzinom. Durch Gaschromatographie und Massenspektrometrie konnten in der Leber von Dialysepatienten in hoher Menge Phthalatweichmacher nachgewiesen werden (5–11 ppm); daneben fanden sich bei einem Patienten in beträchtlicher Menge normalerweise nicht vorkommende, cholesterinähnliche Steroide. Durch Rasterelektronenmikroskopie und Röntgenfluoreszenz-Mikroanalyse ließen sich in Leber und Milz zahlreiche Partikel von mehreren μ-Größe in Makrophagen nachweisen. Entsprechende Einschlüsse konnten bei nichtdialysierten Kontrollindividuen nie gefunden werden. Das Energiespektrum der Partikel zeigte einen scharfen Si-Peak mit geringer Beimengung von Al und Cl. Die Partikel entsprachen in Form und Energiespektrum dem Abrieb von Silikonschläuchen nach Einwirkung von Rollerpumpen. Partikel mit reinem Cl-Peak als Hinweis auf PVC-haltige Partikel konnten bei Patienten mit Silikoneinschlußkörpern nicht nachgewiesen werden. Wegen der beobachteten klinischen Komplikationen müssen aus den vorgelegten Ergebnissen Konsequenzen für die Herstellung von Dialysematerial gezogen werden.
    Notes: Summary We studied autopsy material of 47 patients who were dialysed between 1969 and 1980 in one center in which silicone tubing was used. In addition, we examined ten patients from two other centers where silicone tubing was not routinely used. In 40 patients with exposure to silicone tubing who were dialysed for up to 53 months, no foreign material was demonstrable. In seven patients who were dialysed for periods between 52 and 165 months, light microscopy and electron microscopy showed varying amounts of foreign material in macrophages and giant cells of lung, liver, spleen, bone marrow, skin, thoracic and abdominal lymph nodes. No such material was found in brain, heart, kidney or endocrine organs. No epitheloid cell reaction, necrosis or fibrosis was observed. The material was non-isotropic, non-crystalline, and did not take up routine stains. Electron microscopy showed its presence within lysosomal membranes. In addition, in some patients who had been dialysed for much shorter periods of time, similar material could be demonstrated in liver biopsies obtained in vivo. No such material was observed in ten long-term dialysis patients of two centers where silicone tubing was not routinely used. All positive patients had hepatosplenomegaly, some had elevated transaminases, one patient had hypersplenism with pancytopenia and one patient had bile duct carcinoma. Gaschromatography with mass spectrometry of livers of dialysed patients showed high concentrations of phthalate plasticizer (5–10 ppm) and in one patient cholesterol-like steroids which were not found in normal livers. Surface scanning electron microscopy with non-dispersive X-ray fluorescence analysis revealed the presence of numerous particles up to 10 µ, in liver and spleen of dialysed patients but of not control patients. The particles showed a characteristic Si peak with a concomitant small contribution of Al and Cl. The particles were identical with filing of silicone tubing exposed to roller pumps. No material exhibiting a pure Cl peak (as evidence for PVC) was demonstrable in patients with positive silicone inclusions. Because of its clinical consequences, the observation will have implications for manufacturing of dialysis devices.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    Electronic Resource
    Electronic Resource
    Springer
    Diabetologia 36 (1993), S. 1113-1117 
    ISSN: 1432-0428
    Keywords: Diabetes mellitus ; uraemia ; haemodialysis ; cardiovascular death ; myocardial infarction ; hypertension
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The objective of this study was to examine diabetic patients at the time of admission to maintenance haemodialysis and to follow them for 36 months in order to define predictors of cardiovascular and non-cardiovascular death. This prospective study comprised all consecutive diabetic patients admitted to 28 German dialysis centres between January 1985 and October 1987; 196 patients were examined, 67 Type 1 (insulin-dependent) diabetic (43 male, 24 female; median age 49 years, range 22–73) and 129 Type 2 (non-insulin-dependent) diabetic patients (54 male, 75 female; 64 years, range 37–82). Outcome measures were death, i.e. myocardial infarction, sudden death, cardiac death of other causes, stroke and noncardiovascular death. Actuarial survival 36 months after the beginning of dialysis was similar in Type 1 (40%) and Type 2 diabetic patients (43%) despite the age difference. Causes of death were myocardial infarction (18%), sudden death (18%), other cardiac causes (18%); stroke (6%); septicaemia (17%) mostly originating from diabetic foot problems; and interruption of therapy. Survival rates and the proportion dying from cardiac causes were similar in patients with diabetic nephropathy or with other primary chronic renal disease and coincidental diabetes. On dialysis, de novo amaurosis or de novo amputation was not observed in any patient. The strongest predictor of myocardial infarction or sudden death was serum lipids on admission. Duration of hypertension, blood pressure at the time of admission to dialysis, left ventricular hypertrophy or end-diastolic diameter by echocardiography, Sokolow index and average predialysis blood pressure, smoking, interdialytic weight gain and type of dialysis were not predictive of cardiovascular death or death by all causes. Patients with myocardial infarction were more frequently male (70% of myocardial infarction), tended to be younger, more frequently had a history of myocardial infarction (relative risk 3.0) and more frequently had angina pectoris, proliferative retinopathy (relative risk 2.8) or somatosensory polyneuropathy (relative risk 3.0). Patients dying from myocardial infarction or other cardiac causes had more frequent episodes of intradialytic hypotension and tended to be less frequently on beta blocker treatment. We conclude that cardiac death accounts for most fatalities of diabetic patients on dialysis. Some, but not all, classic risk factors are predictive of cardiac death.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    ISSN: 1432-0428
    Keywords: Diabetes mellitus ; renal sodium transport ; Tamm Horsfall glycoprotein ; furosemide
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary In the present study, 8 Type 1 diabetic patients with normal creatinine clearance and 8 matched controls were examined. Tamm Horsfall glycoprotein was isolated with the NaCl precipitation procedure. Its purity was checked by gelelectrophoresis, immunodiffusion and isoelectric focussing. Tamm Horsfall glycoprotein of diabetic patients had higher glucose (p〈0.05) and lower N-acetylneuraminic acid content (p〈0.01) than controls. 14C-furosemide binding by Tamm Horsfall glycoprotein was examined using an Amicon ultrafiltration system at 0 °C. In nominally sodium-free medium, furosemide binding by Tamm Horsfall glycoprotein was significantly (p〈0.01) higher in diabetic patients than in matched controls. The increment of binding capacity with sodium was similar in controls and diabetic patients so that maximal binding capacity in a NaCl system was 1.7±0.3 in controls and 3.64±0.5 in diabetic patients (p〈0.025). Half maximal furosemide binding by Tamm Horsfall glycoprotein occured at 1.4±0.2mmol Na/l in controls and 0.52±0.12 in diabetic patients (p〈0.01). Abnormal radiofurosemide binding of Tamm Horsfall glycoprotein of diabetic patients may be the consequence of abnormal postribosomal modification of the glycoprotein which is synthesized in an insulin- and glucose-sensitive nephron segment.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 58 (1980), S. 1-15 
    ISSN: 1432-1440
    Keywords: Phosphate ; Calcium ; Phosphate-depletion ; Parathyroid hormone ; Vitamin-D ; Rhabdomyolysis ; Cardiac insufficiency ; Haemolysis ; Osteomalacia ; Phosphat ; Calcium ; Phosphat-Depletion ; Parathormon ; Vitamin D ; Myolyse ; Herzinsuffizienz ; Hämolyse ; Osteomalazie
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammensetzung Die kritische und lebenswichtige Rolle von anorganischem Phosphat ist in der Veterinärmedizin und der tierexperimentellen Forschung seit Jahrzehnten bekannt. Das Syndrom der Phosphat-Depletion fand in der Klinik jedoch erst seit kurzem stärkere Beachtung. Eine Hypophosphatämie wird bei folgenden Krankheitsbildern gehäuft beobachtet: chronischer Alkoholismus, Erholungsphase der diabetischen Ketoazidose, parenterale Ernährung mit Phosphat-freien Lösungen, schwere respiratorische Alkalose und Fruktose-Infusion. Die Organfunktionsstörungen bei Hypophosphatämie sind auf die Verarmung des Zytoplasmas an anorganischem Phosphat zurückzuführen. Eine derartige Phosphat-Verarmung kann (1) durch negative Phosphat-Bilanz des Gesamtorganismus als Folge renaler oder intestinaler Phosphat-Verluste oder (2) ohne negative äußere Phosphat-Bilanz durch Verschiebung von Phosphat aus dem extra- in den intrazellulären Raum auftreten. Die Phosphat-Depletion beeinträchtigt im Prinzip die Funktion aller Organe. Klinisch stehen bei der akuten Phosphat-Depletion Funktionsstörungen der Skelettmuskulatur (Rhabdomyolyse mit myoglobinurischem akutem Nierenversagen), Herzmuskulatur (akute Herzinsuffizienz) und des hämatologischen Systems (Hämolyse, gestörte Leukozyten- und Thrombozytenfunktion) im Vordergrund, während bei chronischer Phosphat-Depletion Skelettstörungen (Osteomalazie) vorherrschen. Die Organfunktionsstörungen sind wahrscheinlich auf verminderte Synthese von ATP und anderen organischen Phosphat-Metaboliten zurückzuführen. Verminderte 2,3-DPG-Spiegel in Erythrozyten und die hierdurch bedingte Hypoxie sind eine weitere mögliche Ursache von Organfunktionsstörungen.
    Notes: Summary The essential and critical role of inorganic phosphate has been known in veterinary medicine and experimental research on animals for decades. However, only recently has the phosphate depletion syndrome found widespread attention by clinicians. Hypophosphatemia is usually observed in the following clinical situations: chronic alcoholism, recovery phase of diabetic ketoacidosis, administration of phosphate-free solutions in parenteral nutrition, severe respiratory alkalosis, and infusion of fructose. Disturbed organ function in hypophosphatemia is the result of a depletion of inorganic phosphate in the cytoplasm of somatic cells. Such phosphate depletion may be due to either of the following mechanisms or a combination of both. (1) Negative external phosphate balance resulting from phosphate loss in urine or feces or (2) translocation of phosphate from the extracellular into the intracellular space with or without concomitant negative external phosphate balance. In principle, phosphate depletion interferes with the function of all somatic cells. In acute phosphate depletion, the clinically most important disturbances are observed in striated muscle (rhabdomyolysis with myoglobinuric acute renal failure), heart muscle (acute heart failure), and hematological systems (hemolysis, disturbed leukocyte and thrombocyte functions). In contrast, in chronic phosphate depletion skeletal abnormalities (osteomalacia) predominate. Organ disturbances are thought to result from diminished synthesis of ATP and other organic phosphate esters and/or from hypoxia secondary to changes in erythrocyte 2,3-DPG.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 58 (1980), S. 575-580 
    ISSN: 1432-1440
    Keywords: Nephrolithiasis ; Hypercalciuria ; Natrium ; Blutdruck ; Phosphat ; Risikofaktoren ; Nephrolithiasis ; Hypercalciuria ; Sodium ; Hypertension ; Riskfactors ; Plasma phosphate
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary In the present investigation 238 randomly selected male individuals of the general population (age 19–41 years) and 42 age-matched male patients with recurrent renal stone formation (calcium oxalate and/or calcium phosphate) were studied under outpatient conditions without dietary restrictions. Urinary Na excretion was 207 ± 82 mmol/24 h (range 55–570) in controls and 208 ± 100 (range 76–575) in recurrent renal stone formers. Both in controls (r=0.36;p 〈 0.01) and in stone formers (r=0.4;p 〈 0.01) a significant correlation was observed between urinary excretion of sodium and calcium. Urinary sodium excretion was unrelated to systolic or diastolic blood pressure in normotensive or hypertensive individuals. This finding indicates that factors other than sodium are involved in the maintenance of hypertension. Urinary sodium, presumably an index of intake of nutrients, was significantly correlated to several coronary risk factors, e.g. fasting glucose, cholesterol and overweight. There existed a significant inverse relationship between fasting plasma phosphate and urinary sodium, but not between fasting plasma phosphate and serum iPTH or urinary cAMP. This finding points to some function of sodium excretion as one determinant of plasma phosphate.
    Notes: Zusammenfassung In der vorliegenden Untersuchung wurden 238 randomisiert ausgewählte männliche Individuen der Normalbevölkerung (Alter: 19–41 Jahre) und 42 altersgleiche Patienten mit rezidivierender Calcium-Oxalat- und/oder Calcium-Phosphat-Nephrolithiasis verglichen. Die Untersuchungen fanden unter ambulanten Bedingungen ohne diätetische Restriktionen statt. Die Urin-Natriumausscheidung betrug 207 ± 82 mmol/24 h (Bereich 55–570) bei Kontrollen und 208 ± 100 mmol/24 h (Bereich 75–574) bei Stein-Patienten. Sowohl bei Kontrollen (r=0,36,p 〈 0,01) und Patienten (r=0,4,p 〈 0,01) bestand eine signifikante Beziehung zwischen der Natrium- und Calcium-Ausscheidungsrate. Weder bei normotensiven noch bei hypertensiven Individuen konnte eine Beziehung zwischen Urin-Natrium-Ausscheidung zu systolischem oder diastolischem Blutdruck gefunden werden. Das Urin-Natrium als Index der Nahrungsaufnahme war signifikant korreliert mit verschiedenen coronaren Risikofaktoren, z.B. Glukose, Cholesterin und Übergewicht. Es konnte eine signifikante inverse Relation zwischen Urin-Natrium und Plasma-Phosphat gefunden werden, es bestand jedoch keine Beziehung zwischen Plasma-Phosphat und iPTH oder Urin-cAMP. Dieser Befund deutet darauf hin, daß die Natrium-Ausscheidung eine Determinante des Plasma-Phosphates darstellt.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...